Scientists Create “Universal” Donor Organs Where Blood Type Does Not Matter
It is possible to create “universal” donor organs that would eliminate the need to match transplant donor and recipient blood types.
It is possible to create “universal” donor organs that would eliminate the need to match transplant donor and recipient blood types.
Investigators found that aging and bronchiolitis obliterans syndrome are both associated with increased interalveolar communications.
Lung transplant recipients who were given antifungal medications prophylactically to prevent invasive fungal infections had lower rates of mortality.
An increased number of pack-years smoking history may decrease the probability of 1-year survival following single or double lung transplantation.
Thoracic organ transplantation remains a viable treatment option in patients with Eisenmenger Syndrome, although these patients are considered higher risk than other potential transplant recipients.
The FDA has granted Orphan Drug Designation to Tacrolimus Inhalation Powder (TFF Pharmaceuticals) for prophylaxis of lung allograft rejection.
Patients receiving lung transplants who had pneumocystis pneumonia had higher mortality rates than those without pneumocystis pneumonia.
New rules include reimbursing donors for lost wages and tightening standards for organ procurement organizations that collect organs from deceased donors.
Early-onset pneumonia with multidrug-resistant organisms is a major concern for patients who have received a liver transplant, and pre- and intra-operative risk factors influence its development, according to study data presented at The American Association for the Study of Liver Diseases’ The Liver Meeting, held November 8 to 12, 2019 in Boston, Massachusetts. In an…
Despite increasing numbers of organ donations and optimized organ recovery, the current supply is not sufficient to meet current and future organ needs.